1. Home
  2. FCUV vs BDRX Comparison

FCUV vs BDRX Comparison

Compare FCUV & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Focus Universal Inc.

FCUV

Focus Universal Inc.

HOLD

Current Price

$8.71

Market Cap

1.6M

Sector

Industrials

ML Signal

HOLD

Logo Biodexa Pharmaceuticals plc

BDRX

Biodexa Pharmaceuticals plc

HOLD

Current Price

$1.27

Market Cap

1.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCUV
BDRX
Founded
2012
2000
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6M
1.6M
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
FCUV
BDRX
Price
$8.71
$1.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.8M
46.0K
Earning Date
05-12-2026
09-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$255,023.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$0.60
52 Week High
$17.90
$11.88

Technical Indicators

Market Signals
Indicator
FCUV
BDRX
Relative Strength Index (RSI) 62.86 29.78
Support Level $1.47 $1.03
Resistance Level $9.48 $1.50
Average True Range (ATR) 1.67 0.19
MACD 0.09 0.02
Stochastic Oscillator 41.25 19.23

Price Performance

Historical Comparison
FCUV
BDRX

About FCUV Focus Universal Inc.

Focus Universal Inc focuses on commercializing universal smart technology and financial reporting software. It plans to utilize its universal smart technology for smart meters and automation systems, which will be incorporated into IoT devices. The company has developed the five proprietary platform technologies: device on a chip; universal smart instrumentation platform (USIP); 5G ultra-narrowband technology; ultra-narrowband power line communication (PLC) technology; and its financial reporting software. The company consists of two segments: LED and IoT Installation Services, and SEC Financial Software segment. It derives the majority of the revenue from LED and IoT Installation Services segment which handles LED and IoT installation and management business.

About BDRX Biodexa Pharmaceuticals plc

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Share on Social Networks: